Knowledge
June 17, 2023
Pros & Cons of lipid nanoparticles for mRNA delivery
Lipid nanoparticles are highly valued tools in the field of mRNA delivery, making them essential for various therapeutic and research approaches. In this article, we will take a look at the pros and cons of LNPs in mRNA delivery.
June 15, 2023
mRNA technology simply explained
New advances in mRNA technology are happening regularly and rapidly. The prevention and treatment of viruses and immunogenic diseases has become possible through new therapeutics that use messenger RNA to help the body produce specific proteins. Nevertheless, the heightened demand for mRNA drugs leads to challenges for its production.
June 13, 2023
Non-viral vectors in gene therapy: LNPs in the spotlight
Non-viral vectors play an increasingly important role in biomedical research and therapy, including gene therapy. In this article, we will discuss the role of non-viral vectors for this specific purpose.
June 13, 2023
Navigating GMP Annex 1: How Single-Use Assemblies will Comply
GMP Annex 1 significantly impacts the use of single-use assemblies in fluid management processes within the biopharmaceutical industry. It requires manufacturers and stakeholders to adopt a risk-based approach, implement proper controls, and ensure the integrity and sterility of single-use systems.
June 6, 2023
Where are lipid nanoparticles (LNPs) used?
Lipid nanoparticles are multifunctional tools used in a variety of different applications, supporting mRNA as a valuable instrument in medicine and research. In this article, we will shed light on what the different applications of LNPs are.
May 9, 2023
Transport & Storage of Antibody Drug Conjugates (ADCs)
ADCs can be described as a new rising star among biopharmaceutics. They are able to specifically target and destroy cancer cells very effectively. Their levels of toxicity can vary depending on several factors, including their specific design and the potency of the cytotoxic drug. This is why safe handling in between facilities is such an important issue and must not be taken lightly.
May 8, 2023
FDA approved antibody-drug conjugates for cancer therapy
ADCs offer new, highly promising approaches in the therapy of various cancer types, and the number of approved ADCs is continuously growing. In this article, we will have a look at ADCs currently approved.
April 26, 2023
Bioconjugates: Examples & Applications
Bioconjugates are powerful tools in several areas of life sciences and beyond. In this article, we will have a look at the technology in general as well as at examples of bioconjugates in specific fields.
April 25, 2023
Examples of Antibody-drug conjugates
Depending on their constituents, ADCs are extremely variable and can be used for several, very distinct purposes. In this article, we will present you 5 examples of ADCs and their respective characteristics.
April 25, 2023
ADC technology simply explained
ADC technology has revolutionized several fields in medicine and research. In this article, we will shed light on this groundbreaking technology.
April 24, 2023
Antibody drug conjugates: 7 facts about ADCs
Antibody drug conjugates (ADCs) are a rapidly growing field of interest in biopharmaceutics. In comparison to conventional chemotherapy treatments, ADCs have the potential to destroy cancerous cells without damaging healthy cells in the process. In this article we will give you an introduction to this important and rapidly growing field.
April 24, 2023
Safe Filling & Aliquoting of Antibody Drug Conjugates (ADCs)
The safe handling of ADCs or other HPAPIs is a complex and elaborate process that requires specialized facilities and a safe, sterile environment. The filling/aliquoting step in particular calls for great care and specific equipment to ensure sterility and rule out any potential cross-contamination as well as potential harm to handling staff.